Health Catalyst Inc. Stock News

Wall Street analysts expect that Health Catalyst, Inc. (NASDAQ:HCAT) will post sales of $63.18 million for the current quarter, according to Zacks Investment Research. Six analysts have provided estimates for Health Catalysts earnings, with the highest sales estimate coming in at $63.76 million and the lowest estimate coming in at $62.86 million. Health Catalyst posted []

Equities analysts predict that Health Catalyst, Inc. (NASDAQ:HCAT) will announce earnings of ($0.21) per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Health Catalysts earnings, with the highest EPS estimate coming in at ($0.14) and the lowest estimate coming in at ($0.34). Health Catalyst reported earnings []

Health Catalyst (NASDAQ:HCAT) and Magnite (NASDAQ:MGNI) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Health Catalyst and Magnites net margins, return on equity and return on []

Zacks Investment Research lowered shares of Health Catalyst (NASDAQ:HCAT) from a hold rating to a sell rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks, Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake []

Goldman Sachs Group Inc. lifted its stake in Health Catalyst, Inc. (NASDAQ:HCAT) by 233.2% in the 2nd quarter, HoldingsChannel reports. The firm owned 101,040 shares of the companys stock after buying an additional 70,712 shares during the quarter. Goldman Sachs Group Inc.s holdings in Health Catalyst were worth $5,609,000 at the end of the most []

Health Catalyst, Inc. (NASDAQ:HCAT) CFO Bryan Truman Hunt sold 957 shares of the businesss stock in a transaction on Friday, November 12th. The stock was sold at an average price of $49.40, for a total value of $47,275.80. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC []

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2021 Results - Earnings Call Transcript

SALT LAKE CITY, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,

This stock had been reporting losses but posted a break-even quarter in the more recent print and that could start a new trend.

SALT LAKE CITY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations

SALT LAKE CITY, Aug. 12, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, t

SALT LAKE CITY, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizat

SALT LAKE CITY, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizat

Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2021 Results - Earnings Call Transcript

ALBUQUERQUE, N.M. and SALT LAKE CITY, Aug. 6, 2021 /PRNewswire/ -- Twistle by Health Catalyst, Inc. (Nasdaq: HCAT) ("Twistle"), a secure communication platform that engages patients in their care, wi